avelumab,paclitaxel,pelareorep
pfizer,merck,oncolytics biotech
['breast', 'bracelet-1']
dr. amy clark during the oral presentation of data from bracelet-1 at #asco23. join us monday june 5 at 8am et for a discussion of this exciting #breastcancer data: cc: #breastcancerresearch #asco2023 #biotech #oncology 
Oncolytics is developing pelareorep, an IV delivered I-O virus, promoting an inflamed tumor: waking the immune system.
Contact company directly: https://t.co/sNAsxxzRk5